nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—head and neck cancer	0.56	1	CiPCiCtD
Clofarabine—RRM2—Hydroxyurea—head and neck cancer	0.172	0.482	CbGbCtD
Clofarabine—RRM1—Hydroxyurea—head and neck cancer	0.172	0.482	CbGbCtD
Clofarabine—ABCG2—Fluorouracil—head and neck cancer	0.00746	0.0209	CbGbCtD
Clofarabine—ABCG2—Docetaxel—head and neck cancer	0.0057	0.0159	CbGbCtD
Clofarabine—RRM1—larynx—head and neck cancer	0.00192	0.228	CbGeAlD
Clofarabine—Catheter related infection—Fluorouracil—head and neck cancer	0.00172	0.0442	CcSEcCtD
Clofarabine—RRM2—G1/S-Specific Transcription—CCNA1—head and neck cancer	0.00172	0.0512	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00156	0.0466	CbGpPWpGaD
Clofarabine—Death—Docetaxel—head and neck cancer	0.00146	0.0374	CcSEcCtD
Clofarabine—Device related infection—Fluorouracil—head and neck cancer	0.00134	0.0345	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00129	0.0384	CbGpPWpGaD
Clofarabine—POLA1—G1/S-Specific Transcription—CCNA1—head and neck cancer	0.00117	0.035	CbGpPWpGaD
Clofarabine—RRM2—Vinorelbine—Vinblastine—head and neck cancer	0.0011	1	CbGdCrCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00104	0.031	CbGpPWpGaD
Clofarabine—DCK—Pyrimidine metabolism—DPYD—head and neck cancer	0.00103	0.0307	CbGpPWpGaD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—CCNA1—head and neck cancer	0.00101	0.0301	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000855	0.0255	CbGpPWpGaD
Clofarabine—RRM2—G1/S-Specific Transcription—TYMS—head and neck cancer	0.000828	0.0247	CbGpPWpGaD
Clofarabine—Septic shock—Fluorouracil—head and neck cancer	0.00077	0.0198	CcSEcCtD
Clofarabine—RRM1—hair follicle—head and neck cancer	0.00076	0.0902	CbGeAlD
Clofarabine—RRM1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000739	0.022	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CEBPA—head and neck cancer	0.000738	0.022	CbGpPWpGaD
Clofarabine—RRM2—mouth—head and neck cancer	0.000718	0.0852	CbGeAlD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—CCNA1—head and neck cancer	0.00069	0.0206	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000608	0.0181	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CEBPA—head and neck cancer	0.000607	0.0181	CbGpPWpGaD
Clofarabine—Enterocolitis—Docetaxel—head and neck cancer	0.000604	0.0155	CcSEcCtD
Clofarabine—RRM1—E2F transcription factor network—XRCC1—head and neck cancer	0.000601	0.0179	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000591	0.0176	CbGpPWpGaD
Clofarabine—DCK—Pyrimidine metabolism—TYMS—head and neck cancer	0.000587	0.0175	CbGpPWpGaD
Clofarabine—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.000583	0.015	CcSEcCtD
Clofarabine—POLA1—G1/S-Specific Transcription—TYMS—head and neck cancer	0.000566	0.0169	CbGpPWpGaD
Clofarabine—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.000543	0.014	CcSEcCtD
Clofarabine—Pericarditis—Fluorouracil—head and neck cancer	0.000538	0.0138	CcSEcCtD
Clofarabine—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000537	0.0138	CcSEcCtD
Clofarabine—POLA1—parotid gland—head and neck cancer	0.000523	0.0621	CbGeAlD
Clofarabine—RRM1—Nucleotide metabolism—DPYD—head and neck cancer	0.000522	0.0156	CbGpPWpGaD
Clofarabine—Multi-organ failure—Docetaxel—head and neck cancer	0.000515	0.0132	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—XRCC1—head and neck cancer	0.000495	0.0148	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000487	0.0145	CbGpPWpGaD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—TYMS—head and neck cancer	0.000487	0.0145	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.000481	0.0143	CbGpPWpGaD
Clofarabine—DCK—Purine metabolism—GPX1—head and neck cancer	0.000431	0.0129	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide metabolism—DPYD—head and neck cancer	0.000429	0.0128	CbGpPWpGaD
Clofarabine—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.000418	0.0108	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—CEBPA—head and neck cancer	0.000415	0.0124	CbGpPWpGaD
Clofarabine—Pericardial effusion—Docetaxel—head and neck cancer	0.000409	0.0105	CcSEcCtD
Clofarabine—DCK—Nucleotide metabolism—DPYD—head and neck cancer	0.000401	0.012	CbGpPWpGaD
Clofarabine—Rash generalised—Docetaxel—head and neck cancer	0.000395	0.0101	CcSEcCtD
Clofarabine—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.000391	0.01	CcSEcCtD
Clofarabine—Cellulitis—Vinblastine—head and neck cancer	0.000389	0.01	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—CCNA1—head and neck cancer	0.000388	0.0116	CbGpPWpGaD
Clofarabine—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000386	0.00994	CcSEcCtD
Clofarabine—Bone pain—Vinblastine—head and neck cancer	0.00037	0.00951	CcSEcCtD
Clofarabine—Prurigo—Docetaxel—head and neck cancer	0.000363	0.00934	CcSEcCtD
Clofarabine—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.000348	0.00895	CcSEcCtD
Clofarabine—Creatinine increased—Hydroxyurea—head and neck cancer	0.000339	0.00872	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—XRCC1—head and neck cancer	0.000339	0.0101	CbGpPWpGaD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—head and neck cancer	0.000333	0.00994	CbGpPWpGaD
Clofarabine—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.000329	0.00846	CcSEcCtD
Clofarabine—Lymphopenia—Docetaxel—head and neck cancer	0.000328	0.00843	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000327	0.00976	CbGpPWpGaD
Clofarabine—DCK—parotid gland—head and neck cancer	0.000323	0.0383	CbGeAlD
Clofarabine—RRM2—lymphoid tissue—head and neck cancer	0.000322	0.0382	CbGeAlD
Clofarabine—Neoplasm—Vinblastine—head and neck cancer	0.00032	0.00823	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00032	0.00954	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—TYMS—head and neck cancer	0.000313	0.00935	CbGpPWpGaD
Clofarabine—DCK—saliva-secreting gland—head and neck cancer	0.000309	0.0367	CbGeAlD
Clofarabine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000308	0.00793	CcSEcCtD
Clofarabine—POLA1—thyroid gland—head and neck cancer	0.000306	0.0363	CbGeAlD
Clofarabine—Mucosal inflammation—Docetaxel—head and neck cancer	0.000303	0.00779	CcSEcCtD
Clofarabine—RRM1—Nucleotide metabolism—TYMS—head and neck cancer	0.000297	0.00887	CbGpPWpGaD
Clofarabine—Necrosis—Fluorouracil—head and neck cancer	0.000296	0.00762	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CCNA1—head and neck cancer	0.000294	0.00876	CbGpPWpGaD
Clofarabine—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.000294	0.00755	CcSEcCtD
Clofarabine—RRM2—thyroid gland—head and neck cancer	0.000292	0.0347	CbGeAlD
Clofarabine—Neoplasm—Hydroxyurea—head and neck cancer	0.000292	0.00751	CcSEcCtD
Clofarabine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.000287	0.00739	CcSEcCtD
Clofarabine—Deafness—Vinblastine—head and neck cancer	0.000287	0.00739	CcSEcCtD
Clofarabine—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.000282	0.00725	CcSEcCtD
Clofarabine—RRM1—Nucleotide metabolism—GPX1—head and neck cancer	0.000281	0.00839	CbGpPWpGaD
Clofarabine—Febrile neutropenia—Docetaxel—head and neck cancer	0.000279	0.00717	CcSEcCtD
Clofarabine—Polyp—Docetaxel—head and neck cancer	0.000276	0.00709	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CCNA1—head and neck cancer	0.000276	0.00822	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000272	0.00812	CbGpPWpGaD
Clofarabine—RRM1—lymphoid tissue—head and neck cancer	0.000267	0.0317	CbGeAlD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000266	0.00793	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CCNA1—head and neck cancer	0.000265	0.00792	CbGpPWpGaD
Clofarabine—Oral candidiasis—Docetaxel—head and neck cancer	0.000264	0.00679	CcSEcCtD
Clofarabine—RRM2—head—head and neck cancer	0.000259	0.0308	CbGeAlD
Clofarabine—RRM2—E2F transcription factor network—TYMS—head and neck cancer	0.000258	0.0077	CbGpPWpGaD
Clofarabine—Cellulitis—Fluorouracil—head and neck cancer	0.000256	0.00657	CcSEcCtD
Clofarabine—Renal failure acute—Hydroxyurea—head and neck cancer	0.000254	0.00653	CcSEcCtD
Clofarabine—Herpes simplex—Fluorouracil—head and neck cancer	0.000252	0.00649	CcSEcCtD
Clofarabine—Cyst—Docetaxel—head and neck cancer	0.000251	0.00645	CcSEcCtD
Clofarabine—RRM2—Nucleotide metabolism—TYMS—head and neck cancer	0.000245	0.0073	CbGpPWpGaD
Clofarabine—RRM1—thyroid gland—head and neck cancer	0.000243	0.0288	CbGeAlD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000242	0.00721	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCNA1—head and neck cancer	0.000241	0.00719	CbGpPWpGaD
Clofarabine—DCK—trachea—head and neck cancer	0.000238	0.0283	CbGeAlD
Clofarabine—RRM2—Nucleotide metabolism—GPX1—head and neck cancer	0.000232	0.00691	CbGpPWpGaD
Clofarabine—DCK—Nucleotide metabolism—TYMS—head and neck cancer	0.000229	0.00682	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000227	0.00679	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000224	0.00669	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000224	0.00667	CbGpPWpGaD
Clofarabine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00022	0.00565	CcSEcCtD
Clofarabine—Rash erythematous—Docetaxel—head and neck cancer	0.000219	0.00563	CcSEcCtD
Clofarabine—Pleural effusion—Docetaxel—head and neck cancer	0.000219	0.00563	CcSEcCtD
Clofarabine—Hepatotoxicity—Docetaxel—head and neck cancer	0.000217	0.00559	CcSEcCtD
Clofarabine—DCK—Nucleotide metabolism—GPX1—head and neck cancer	0.000216	0.00646	CbGpPWpGaD
Clofarabine—RRM1—head—head and neck cancer	0.000215	0.0256	CbGeAlD
Clofarabine—Necrosis—Docetaxel—head and neck cancer	0.000214	0.0055	CcSEcCtD
Clofarabine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.000211	0.00543	CcSEcCtD
Clofarabine—Pancytopenia—Vinblastine—head and neck cancer	0.000211	0.00543	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.00021	0.00625	CbGpPWpGaD
Clofarabine—DCK—lymphoid tissue—head and neck cancer	0.000208	0.0246	CbGeAlD
Clofarabine—Sepsis—Fluorouracil—head and neck cancer	0.000202	0.00519	CcSEcCtD
Clofarabine—Pancreatitis—Hydroxyurea—head and neck cancer	0.000199	0.00511	CcSEcCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000196	0.00585	CbGpPWpGaD
Clofarabine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000194	0.00499	CcSEcCtD
Clofarabine—Pancytopenia—Hydroxyurea—head and neck cancer	0.000192	0.00495	CcSEcCtD
Clofarabine—POLA1—lymph node—head and neck cancer	0.00019	0.0226	CbGeAlD
Clofarabine—Neutropenia—Hydroxyurea—head and neck cancer	0.000189	0.00487	CcSEcCtD
Clofarabine—DCK—thyroid gland—head and neck cancer	0.000189	0.0224	CbGeAlD
Clofarabine—RRM2—G1/S Transition—TYMS—head and neck cancer	0.000187	0.00559	CbGpPWpGaD
Clofarabine—Bone disorder—Docetaxel—head and neck cancer	0.000186	0.00478	CcSEcCtD
Clofarabine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000185	0.00474	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000182	0.00543	CbGpPWpGaD
Clofarabine—RRM2—lymph node—head and neck cancer	0.000182	0.0215	CbGeAlD
Clofarabine—Infestation NOS—Hydroxyurea—head and neck cancer	0.000181	0.00465	CcSEcCtD
Clofarabine—Infestation—Hydroxyurea—head and neck cancer	0.000181	0.00465	CcSEcCtD
Clofarabine—ABCG2—parotid gland—head and neck cancer	0.00018	0.0214	CbGeAlD
Clofarabine—Haemoglobin—Vinblastine—head and neck cancer	0.000179	0.0046	CcSEcCtD
Clofarabine—Haemorrhage—Vinblastine—head and neck cancer	0.000178	0.00457	CcSEcCtD
Clofarabine—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000177	0.00456	CcSEcCtD
Clofarabine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000177	0.00455	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—TYMS—head and neck cancer	0.000177	0.00527	CbGpPWpGaD
Clofarabine—Hearing impaired—Docetaxel—head and neck cancer	0.000176	0.00453	CcSEcCtD
Clofarabine—Stomatitis—Hydroxyurea—head and neck cancer	0.000176	0.00453	CcSEcCtD
Clofarabine—Bone pain—Docetaxel—head and neck cancer	0.000175	0.0045	CcSEcCtD
Clofarabine—ABCG2—saliva-secreting gland—head and neck cancer	0.000172	0.0205	CbGeAlD
Clofarabine—Lethargy—Fluorouracil—head and neck cancer	0.000172	0.00443	CcSEcCtD
Clofarabine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000171	0.00439	CcSEcCtD
Clofarabine—Respiratory failure—Docetaxel—head and neck cancer	0.000171	0.00439	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000169	0.00434	CcSEcCtD
Clofarabine—Hepatocellular injury—Docetaxel—head and neck cancer	0.000168	0.00431	CcSEcCtD
Clofarabine—DCK—head—head and neck cancer	0.000167	0.0199	CbGeAlD
Clofarabine—Haemoglobin—Hydroxyurea—head and neck cancer	0.000163	0.00419	CcSEcCtD
Clofarabine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000162	0.00417	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000162	0.00482	CbGpPWpGaD
Clofarabine—Colitis—Docetaxel—head and neck cancer	0.000161	0.00414	CcSEcCtD
Clofarabine—Irritability—Fluorouracil—head and neck cancer	0.000161	0.00414	CcSEcCtD
Clofarabine—Candida infection—Docetaxel—head and neck cancer	0.00016	0.00412	CcSEcCtD
Clofarabine—Skin exfoliation—Docetaxel—head and neck cancer	0.00016	0.00412	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000158	0.00471	CbGpPWpGaD
Clofarabine—Alopecia—Vinblastine—head and neck cancer	0.000157	0.00404	CcSEcCtD
Clofarabine—Dry skin—Fluorouracil—head and neck cancer	0.000155	0.00398	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000153	0.00458	CbGpPWpGaD
Clofarabine—Neoplasm—Docetaxel—head and neck cancer	0.000152	0.0039	CcSEcCtD
Clofarabine—RRM1—lymph node—head and neck cancer	0.000151	0.0179	CbGeAlD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00015	0.00447	CbGpPWpGaD
Clofarabine—Pulmonary oedema—Docetaxel—head and neck cancer	0.000149	0.00384	CcSEcCtD
Clofarabine—Angiopathy—Hydroxyurea—head and neck cancer	0.000147	0.00378	CcSEcCtD
Clofarabine—Sepsis—Docetaxel—head and neck cancer	0.000146	0.00374	CcSEcCtD
Clofarabine—Chills—Hydroxyurea—head and neck cancer	0.000146	0.00374	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000145	0.00433	CbGpPWpGaD
Clofarabine—Alopecia—Hydroxyurea—head and neck cancer	0.000143	0.00368	CcSEcCtD
Clofarabine—Anaemia—Vinblastine—head and neck cancer	0.000143	0.00368	CcSEcCtD
Clofarabine—Erythema—Hydroxyurea—head and neck cancer	0.000141	0.00363	CcSEcCtD
Clofarabine—Leukopenia—Vinblastine—head and neck cancer	0.000139	0.00356	CcSEcCtD
Clofarabine—Pancytopenia—Fluorouracil—head and neck cancer	0.000139	0.00356	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000137	0.00409	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000136	0.00406	CbGpPWpGaD
Clofarabine—Deafness—Docetaxel—head and neck cancer	0.000136	0.0035	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000136	0.00349	CcSEcCtD
Clofarabine—Hypertension—Vinblastine—head and neck cancer	0.000134	0.00344	CcSEcCtD
Clofarabine—Pneumonia—Fluorouracil—head and neck cancer	0.000131	0.00336	CcSEcCtD
Clofarabine—Anaemia—Hydroxyurea—head and neck cancer	0.00013	0.00336	CcSEcCtD
Clofarabine—RRM1—Metabolism—UROD—head and neck cancer	0.00013	0.00388	CbGpPWpGaD
Clofarabine—Infestation—Fluorouracil—head and neck cancer	0.00013	0.00334	CcSEcCtD
Clofarabine—Infestation NOS—Fluorouracil—head and neck cancer	0.00013	0.00334	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—TYMS—head and neck cancer	0.000128	0.00382	CbGpPWpGaD
Clofarabine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000127	0.00328	CcSEcCtD
Clofarabine—Stomatitis—Fluorouracil—head and neck cancer	0.000127	0.00326	CcSEcCtD
Clofarabine—Leukopenia—Hydroxyurea—head and neck cancer	0.000126	0.00325	CcSEcCtD
Clofarabine—Lethargy—Docetaxel—head and neck cancer	0.000124	0.0032	CcSEcCtD
Clofarabine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000124	0.00318	CcSEcCtD
Clofarabine—Epistaxis—Fluorouracil—head and neck cancer	0.000123	0.00315	CcSEcCtD
Clofarabine—Sinusitis—Fluorouracil—head and neck cancer	0.000122	0.00314	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000122	0.00313	CcSEcCtD
Clofarabine—Pain in extremity—Docetaxel—head and neck cancer	0.000122	0.00313	CcSEcCtD
Clofarabine—Anorexia—Vinblastine—head and neck cancer	0.00012	0.0031	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.00012	0.00358	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000119	0.00307	CcSEcCtD
Clofarabine—Haemoglobin—Fluorouracil—head and neck cancer	0.000117	0.00302	CcSEcCtD
Clofarabine—DCK—lymph node—head and neck cancer	0.000117	0.0139	CbGeAlD
Clofarabine—Haemorrhage—Fluorouracil—head and neck cancer	0.000117	0.003	CcSEcCtD
Clofarabine—Oedema—Hydroxyurea—head and neck cancer	0.000115	0.00296	CcSEcCtD
Clofarabine—Infection—Hydroxyurea—head and neck cancer	0.000114	0.00294	CcSEcCtD
Clofarabine—Paraesthesia—Vinblastine—head and neck cancer	0.000113	0.00292	CcSEcCtD
Clofarabine—Dehydration—Docetaxel—head and neck cancer	0.000113	0.00291	CcSEcCtD
Clofarabine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000113	0.00291	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000113	0.00337	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000113	0.0029	CcSEcCtD
Clofarabine—Skin disorder—Hydroxyurea—head and neck cancer	0.000112	0.00288	CcSEcCtD
Clofarabine—Dry skin—Docetaxel—head and neck cancer	0.000112	0.00287	CcSEcCtD
Clofarabine—Abdominal pain upper—Docetaxel—head and neck cancer	0.000111	0.00286	CcSEcCtD
Clofarabine—Anorexia—Hydroxyurea—head and neck cancer	0.00011	0.00282	CcSEcCtD
Clofarabine—Decreased appetite—Vinblastine—head and neck cancer	0.00011	0.00282	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00011	0.00282	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00011	0.00282	CcSEcCtD
Clofarabine—Pain—Vinblastine—head and neck cancer	0.000108	0.00278	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000108	0.00322	CbGpPWpGaD
Clofarabine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000107	0.00276	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCNA1—head and neck cancer	0.000107	0.0032	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—UROD—head and neck cancer	0.000107	0.0032	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000106	0.00315	CbGpPWpGaD
Clofarabine—ABCG2—thyroid gland—head and neck cancer	0.000105	0.0125	CbGeAlD
Clofarabine—Feeling abnormal—Vinblastine—head and neck cancer	0.000104	0.00268	CcSEcCtD
Clofarabine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000103	0.00266	CcSEcCtD
Clofarabine—Alopecia—Fluorouracil—head and neck cancer	0.000103	0.00265	CcSEcCtD
Clofarabine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000103	0.00264	CcSEcCtD
Clofarabine—Somnolence—Hydroxyurea—head and neck cancer	0.000102	0.00263	CcSEcCtD
Clofarabine—Erythema—Fluorouracil—head and neck cancer	0.000102	0.00261	CcSEcCtD
Clofarabine—Decreased appetite—Hydroxyurea—head and neck cancer	0.0001	0.00258	CcSEcCtD
Clofarabine—DCK—Metabolism—UROD—head and neck cancer	0.0001	0.00299	CbGpPWpGaD
Clofarabine—Pancytopenia—Docetaxel—head and neck cancer	0.0001	0.00257	CcSEcCtD
Clofarabine—Abdominal pain—Vinblastine—head and neck cancer	9.99e-05	0.00257	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	9.95e-05	0.00256	CcSEcCtD
Clofarabine—Fatigue—Hydroxyurea—head and neck cancer	9.93e-05	0.00255	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	9.92e-05	0.00296	CbGpPWpGaD
Clofarabine—Pain—Hydroxyurea—head and neck cancer	9.85e-05	0.00253	CcSEcCtD
Clofarabine—Neutropenia—Docetaxel—head and neck cancer	9.84e-05	0.00253	CcSEcCtD
Clofarabine—Weight decreased—Docetaxel—head and neck cancer	9.52e-05	0.00245	CcSEcCtD
Clofarabine—Feeling abnormal—Hydroxyurea—head and neck cancer	9.5e-05	0.00244	CcSEcCtD
Clofarabine—Pneumonia—Docetaxel—head and neck cancer	9.44e-05	0.00243	CcSEcCtD
Clofarabine—Anaemia—Fluorouracil—head and neck cancer	9.39e-05	0.00242	CcSEcCtD
Clofarabine—Infestation NOS—Docetaxel—head and neck cancer	9.39e-05	0.00241	CcSEcCtD
Clofarabine—Infestation—Docetaxel—head and neck cancer	9.39e-05	0.00241	CcSEcCtD
Clofarabine—Hypersensitivity—Vinblastine—head and neck cancer	9.31e-05	0.00239	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	9.31e-05	0.00239	CcSEcCtD
Clofarabine—Renal failure—Docetaxel—head and neck cancer	9.23e-05	0.00237	CcSEcCtD
Clofarabine—Neuropathy peripheral—Docetaxel—head and neck cancer	9.2e-05	0.00237	CcSEcCtD
Clofarabine—Jaundice—Docetaxel—head and neck cancer	9.15e-05	0.00235	CcSEcCtD
Clofarabine—Stomatitis—Docetaxel—head and neck cancer	9.15e-05	0.00235	CcSEcCtD
Clofarabine—Body temperature increased—Hydroxyurea—head and neck cancer	9.11e-05	0.00234	CcSEcCtD
Clofarabine—Leukopenia—Fluorouracil—head and neck cancer	9.1e-05	0.00234	CcSEcCtD
Clofarabine—Asthenia—Vinblastine—head and neck cancer	9.07e-05	0.00233	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	9.03e-05	0.00269	CbGpPWpGaD
Clofarabine—Hepatobiliary disease—Docetaxel—head and neck cancer	8.88e-05	0.00228	CcSEcCtD
Clofarabine—Epistaxis—Docetaxel—head and neck cancer	8.85e-05	0.00228	CcSEcCtD
Clofarabine—Myalgia—Fluorouracil—head and neck cancer	8.65e-05	0.00222	CcSEcCtD
Clofarabine—Diarrhoea—Vinblastine—head and neck cancer	8.64e-05	0.00222	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—RAD51—head and neck cancer	8.62e-05	0.00257	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	8.52e-05	0.00254	CbGpPWpGaD
Clofarabine—Hypersensitivity—Hydroxyurea—head and neck cancer	8.49e-05	0.00218	CcSEcCtD
Clofarabine—Haemoglobin—Docetaxel—head and neck cancer	8.47e-05	0.00218	CcSEcCtD
Clofarabine—Haemorrhage—Docetaxel—head and neck cancer	8.43e-05	0.00217	CcSEcCtD
Clofarabine—Dizziness—Vinblastine—head and neck cancer	8.36e-05	0.00215	CcSEcCtD
Clofarabine—Urinary tract disorder—Docetaxel—head and neck cancer	8.32e-05	0.00214	CcSEcCtD
Clofarabine—Oedema peripheral—Docetaxel—head and neck cancer	8.3e-05	0.00213	CcSEcCtD
Clofarabine—Oedema—Fluorouracil—head and neck cancer	8.29e-05	0.00213	CcSEcCtD
Clofarabine—Connective tissue disorder—Docetaxel—head and neck cancer	8.28e-05	0.00213	CcSEcCtD
Clofarabine—Asthenia—Hydroxyurea—head and neck cancer	8.27e-05	0.00213	CcSEcCtD
Clofarabine—Urethral disorder—Docetaxel—head and neck cancer	8.26e-05	0.00212	CcSEcCtD
Clofarabine—Infection—Fluorouracil—head and neck cancer	8.24e-05	0.00212	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCNA1—head and neck cancer	8.2e-05	0.00245	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	8.18e-05	0.00244	CbGpPWpGaD
Clofarabine—Nervous system disorder—Fluorouracil—head and neck cancer	8.13e-05	0.00209	CcSEcCtD
Clofarabine—Thrombocytopenia—Fluorouracil—head and neck cancer	8.12e-05	0.00209	CcSEcCtD
Clofarabine—Tachycardia—Fluorouracil—head and neck cancer	8.09e-05	0.00208	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	8.09e-05	0.00241	CbGpPWpGaD
Clofarabine—Vomiting—Vinblastine—head and neck cancer	8.03e-05	0.00207	CcSEcCtD
Clofarabine—Erythema multiforme—Docetaxel—head and neck cancer	7.97e-05	0.00205	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—head and neck cancer	7.95e-05	0.00237	CbGpPWpGaD
Clofarabine—Headache—Vinblastine—head and neck cancer	7.92e-05	0.00204	CcSEcCtD
Clofarabine—Anorexia—Fluorouracil—head and neck cancer	7.91e-05	0.00203	CcSEcCtD
Clofarabine—Diarrhoea—Hydroxyurea—head and neck cancer	7.88e-05	0.00203	CcSEcCtD
Clofarabine—Cardiac disorder—Docetaxel—head and neck cancer	7.82e-05	0.00201	CcSEcCtD
Clofarabine—Flushing—Docetaxel—head and neck cancer	7.82e-05	0.00201	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—head and neck cancer	7.81e-05	0.00233	CbGpPWpGaD
Clofarabine—Hypotension—Fluorouracil—head and neck cancer	7.75e-05	0.00199	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	7.72e-05	0.0023	CbGpPWpGaD
Clofarabine—Angiopathy—Docetaxel—head and neck cancer	7.64e-05	0.00197	CcSEcCtD
Clofarabine—Dizziness—Hydroxyurea—head and neck cancer	7.62e-05	0.00196	CcSEcCtD
Clofarabine—Immune system disorder—Docetaxel—head and neck cancer	7.61e-05	0.00196	CcSEcCtD
Clofarabine—Mediastinal disorder—Docetaxel—head and neck cancer	7.59e-05	0.00195	CcSEcCtD
Clofarabine—Chills—Docetaxel—head and neck cancer	7.56e-05	0.00194	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	7.56e-05	0.00194	CcSEcCtD
Clofarabine—Nausea—Vinblastine—head and neck cancer	7.5e-05	0.00193	CcSEcCtD
Clofarabine—Paraesthesia—Fluorouracil—head and neck cancer	7.45e-05	0.00191	CcSEcCtD
Clofarabine—Alopecia—Docetaxel—head and neck cancer	7.45e-05	0.00191	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	7.44e-05	0.00222	CbGpPWpGaD
Clofarabine—Dyspnoea—Fluorouracil—head and neck cancer	7.39e-05	0.0019	CcSEcCtD
Clofarabine—Mental disorder—Docetaxel—head and neck cancer	7.38e-05	0.0019	CcSEcCtD
Clofarabine—Somnolence—Fluorouracil—head and neck cancer	7.37e-05	0.0019	CcSEcCtD
Clofarabine—Malnutrition—Docetaxel—head and neck cancer	7.33e-05	0.00189	CcSEcCtD
Clofarabine—Erythema—Docetaxel—head and neck cancer	7.33e-05	0.00189	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CCNA1—head and neck cancer	7.33e-05	0.00219	CbGpPWpGaD
Clofarabine—Vomiting—Hydroxyurea—head and neck cancer	7.33e-05	0.00188	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	7.31e-05	0.00218	CbGpPWpGaD
Clofarabine—Rash—Hydroxyurea—head and neck cancer	7.27e-05	0.00187	CcSEcCtD
Clofarabine—Dermatitis—Hydroxyurea—head and neck cancer	7.26e-05	0.00187	CcSEcCtD
Clofarabine—Headache—Hydroxyurea—head and neck cancer	7.22e-05	0.00186	CcSEcCtD
Clofarabine—Decreased appetite—Fluorouracil—head and neck cancer	7.21e-05	0.00185	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	7.16e-05	0.00184	CcSEcCtD
Clofarabine—Back pain—Docetaxel—head and neck cancer	7.09e-05	0.00182	CcSEcCtD
Clofarabine—Pain—Fluorouracil—head and neck cancer	7.09e-05	0.00182	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.06e-05	0.0021	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	6.95e-05	0.00207	CbGpPWpGaD
Clofarabine—Nausea—Hydroxyurea—head and neck cancer	6.84e-05	0.00176	CcSEcCtD
Clofarabine—Feeling abnormal—Fluorouracil—head and neck cancer	6.83e-05	0.00176	CcSEcCtD
Clofarabine—Anaemia—Docetaxel—head and neck cancer	6.78e-05	0.00174	CcSEcCtD
Clofarabine—Leukopenia—Docetaxel—head and neck cancer	6.57e-05	0.00169	CcSEcCtD
Clofarabine—Body temperature increased—Fluorouracil—head and neck cancer	6.56e-05	0.00169	CcSEcCtD
Clofarabine—ABCG2—lymph node—head and neck cancer	6.54e-05	0.00776	CbGeAlD
Clofarabine—Cough—Docetaxel—head and neck cancer	6.4e-05	0.00165	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	6.37e-05	0.0019	CbGpPWpGaD
Clofarabine—Hypertension—Docetaxel—head and neck cancer	6.33e-05	0.00163	CcSEcCtD
Clofarabine—Myalgia—Docetaxel—head and neck cancer	6.24e-05	0.00161	CcSEcCtD
Clofarabine—Arthralgia—Docetaxel—head and neck cancer	6.24e-05	0.00161	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	6.2e-05	0.00159	CcSEcCtD
Clofarabine—Hypersensitivity—Fluorouracil—head and neck cancer	6.11e-05	0.00157	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	6.04e-05	0.0018	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.03e-05	0.0018	CbGpPWpGaD
Clofarabine—Oedema—Docetaxel—head and neck cancer	5.99e-05	0.00154	CcSEcCtD
Clofarabine—Infection—Docetaxel—head and neck cancer	5.95e-05	0.00153	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—RAD51—head and neck cancer	5.89e-05	0.00176	CbGpPWpGaD
Clofarabine—Nervous system disorder—Docetaxel—head and neck cancer	5.87e-05	0.00151	CcSEcCtD
Clofarabine—Pruritus—Fluorouracil—head and neck cancer	5.87e-05	0.00151	CcSEcCtD
Clofarabine—Thrombocytopenia—Docetaxel—head and neck cancer	5.86e-05	0.00151	CcSEcCtD
Clofarabine—POLA1—S Phase—CCND1—head and neck cancer	5.85e-05	0.00175	CbGpPWpGaD
Clofarabine—Tachycardia—Docetaxel—head and neck cancer	5.84e-05	0.0015	CcSEcCtD
Clofarabine—Skin disorder—Docetaxel—head and neck cancer	5.81e-05	0.0015	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—TYMS—head and neck cancer	5.79e-05	0.00173	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.74e-05	0.00171	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.73e-05	0.00171	CbGpPWpGaD
Clofarabine—Anorexia—Docetaxel—head and neck cancer	5.71e-05	0.00147	CcSEcCtD
Clofarabine—Diarrhoea—Fluorouracil—head and neck cancer	5.67e-05	0.00146	CcSEcCtD
Clofarabine—Hypotension—Docetaxel—head and neck cancer	5.59e-05	0.00144	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	5.59e-05	0.00167	CbGpPWpGaD
Clofarabine—Dizziness—Fluorouracil—head and neck cancer	5.48e-05	0.00141	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	5.45e-05	0.0014	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—head and neck cancer	5.43e-05	0.00162	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NAT2—head and neck cancer	5.4e-05	0.00161	CbGpPWpGaD
Clofarabine—Paraesthesia—Docetaxel—head and neck cancer	5.38e-05	0.00138	CcSEcCtD
Clofarabine—Dyspnoea—Docetaxel—head and neck cancer	5.34e-05	0.00137	CcSEcCtD
Clofarabine—Somnolence—Docetaxel—head and neck cancer	5.32e-05	0.00137	CcSEcCtD
Clofarabine—Vomiting—Fluorouracil—head and neck cancer	5.27e-05	0.00136	CcSEcCtD
Clofarabine—Rash—Fluorouracil—head and neck cancer	5.23e-05	0.00134	CcSEcCtD
Clofarabine—Dermatitis—Fluorouracil—head and neck cancer	5.22e-05	0.00134	CcSEcCtD
Clofarabine—Decreased appetite—Docetaxel—head and neck cancer	5.2e-05	0.00134	CcSEcCtD
Clofarabine—Headache—Fluorouracil—head and neck cancer	5.2e-05	0.00134	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TYMS—head and neck cancer	5.17e-05	0.00154	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Docetaxel—head and neck cancer	5.17e-05	0.00133	CcSEcCtD
Clofarabine—Fatigue—Docetaxel—head and neck cancer	5.16e-05	0.00133	CcSEcCtD
Clofarabine—Pain—Docetaxel—head and neck cancer	5.12e-05	0.00132	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	5.09e-05	0.00152	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.98e-05	0.00148	CbGpPWpGaD
Clofarabine—Feeling abnormal—Docetaxel—head and neck cancer	4.93e-05	0.00127	CcSEcCtD
Clofarabine—Nausea—Fluorouracil—head and neck cancer	4.93e-05	0.00127	CcSEcCtD
Clofarabine—Gastrointestinal pain—Docetaxel—head and neck cancer	4.9e-05	0.00126	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.81e-05	0.00144	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.8e-05	0.00143	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—DPYD—head and neck cancer	4.74e-05	0.00141	CbGpPWpGaD
Clofarabine—Abdominal pain—Docetaxel—head and neck cancer	4.73e-05	0.00122	CcSEcCtD
Clofarabine—Body temperature increased—Docetaxel—head and neck cancer	4.73e-05	0.00122	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	4.59e-05	0.00137	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.56e-05	0.00136	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—YAP1—head and neck cancer	4.5e-05	0.00134	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	4.49e-05	0.00134	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NAT2—head and neck cancer	4.45e-05	0.00133	CbGpPWpGaD
Clofarabine—Hypersensitivity—Docetaxel—head and neck cancer	4.41e-05	0.00113	CcSEcCtD
Clofarabine—Asthenia—Docetaxel—head and neck cancer	4.29e-05	0.0011	CcSEcCtD
Clofarabine—Pruritus—Docetaxel—head and neck cancer	4.24e-05	0.00109	CcSEcCtD
Clofarabine—DCK—Metabolism—NAT2—head and neck cancer	4.16e-05	0.00124	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.12e-05	0.00123	CbGpPWpGaD
Clofarabine—Diarrhoea—Docetaxel—head and neck cancer	4.1e-05	0.00105	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.07e-05	0.00121	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UROD—head and neck cancer	4.01e-05	0.0012	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.97e-05	0.00119	CbGpPWpGaD
Clofarabine—Dizziness—Docetaxel—head and neck cancer	3.96e-05	0.00102	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—TYMS—head and neck cancer	3.96e-05	0.00118	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—DPYD—head and neck cancer	3.9e-05	0.00116	CbGpPWpGaD
Clofarabine—Vomiting—Docetaxel—head and neck cancer	3.81e-05	0.000979	CcSEcCtD
Clofarabine—Rash—Docetaxel—head and neck cancer	3.77e-05	0.00097	CcSEcCtD
Clofarabine—Dermatitis—Docetaxel—head and neck cancer	3.77e-05	0.00097	CcSEcCtD
Clofarabine—Headache—Docetaxel—head and neck cancer	3.75e-05	0.000964	CcSEcCtD
Clofarabine—RRM2—Metabolism—YAP1—head and neck cancer	3.7e-05	0.0011	CbGpPWpGaD
Clofarabine—DCK—Metabolism—DPYD—head and neck cancer	3.65e-05	0.00109	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.59e-05	0.00107	CbGpPWpGaD
Clofarabine—Nausea—Docetaxel—head and neck cancer	3.56e-05	0.000914	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—TYMS—head and neck cancer	3.54e-05	0.00106	CbGpPWpGaD
Clofarabine—DCK—Metabolism—YAP1—head and neck cancer	3.46e-05	0.00103	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.4e-05	0.00101	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.23e-05	0.000964	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.23e-05	0.000964	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.93e-05	0.000874	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—head and neck cancer	2.91e-05	0.000869	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.8e-05	0.000836	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.71e-05	0.000809	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TYMS—head and neck cancer	2.7e-05	0.000805	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTM1—head and neck cancer	2.67e-05	0.000796	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND1—head and neck cancer	2.61e-05	0.000777	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GPX1—head and neck cancer	2.56e-05	0.000762	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP1A1—head and neck cancer	2.53e-05	0.000755	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.4e-05	0.000717	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.29e-05	0.000683	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.29e-05	0.000682	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TYMS—head and neck cancer	2.22e-05	0.000663	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—head and neck cancer	2.2e-05	0.000656	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—head and neck cancer	2.2e-05	0.000656	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK3—head and neck cancer	2.15e-05	0.000641	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GPX1—head and neck cancer	2.1e-05	0.000628	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—head and neck cancer	2.09e-05	0.000624	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1A1—head and neck cancer	2.08e-05	0.000622	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TYMS—head and neck cancer	2.08e-05	0.00062	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—head and neck cancer	2.05e-05	0.000613	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK1—head and neck cancer	2.04e-05	0.00061	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.99e-05	0.000595	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GPX1—head and neck cancer	1.97e-05	0.000587	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1A1—head and neck cancer	1.95e-05	0.000581	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—head and neck cancer	1.78e-05	0.000532	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—head and neck cancer	1.72e-05	0.000512	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAT2—head and neck cancer	1.66e-05	0.000496	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.64e-05	0.00049	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.56e-05	0.000467	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—head and neck cancer	1.5e-05	0.000449	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK3—head and neck cancer	1.47e-05	0.000438	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—DPYD—head and neck cancer	1.46e-05	0.000435	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK1—head and neck cancer	1.4e-05	0.000417	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—YAP1—head and neck cancer	1.38e-05	0.000413	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—head and neck cancer	1.31e-05	0.000391	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—head and neck cancer	1.24e-05	0.00037	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—head and neck cancer	1.17e-05	0.00035	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—head and neck cancer	1.16e-05	0.000345	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—head and neck cancer	1.08e-05	0.000322	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—head and neck cancer	1.01e-05	0.000301	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—head and neck cancer	9.26e-06	0.000276	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—head and neck cancer	8.31e-06	0.000248	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—head and neck cancer	8.22e-06	0.000245	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GPX1—head and neck cancer	7.87e-06	0.000235	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1A1—head and neck cancer	7.79e-06	0.000232	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—head and neck cancer	7.62e-06	0.000227	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—head and neck cancer	7.56e-06	0.000226	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—head and neck cancer	7.12e-06	0.000212	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—head and neck cancer	6.23e-06	0.000186	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—head and neck cancer	5.82e-06	0.000174	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—head and neck cancer	4.63e-06	0.000138	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—head and neck cancer	4.04e-06	0.000121	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—head and neck cancer	2.85e-06	8.5e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—head and neck cancer	2.33e-06	6.95e-05	CbGpPWpGaD
